Human medicines European public assessment report (EPAR): Tafamidis Accord, tafamidis, Date of authorisation: 18/09/2026, Status: Authorised

Medicine shortages and availability issues

Outcomes of imposed non-interventional post-authorisation safety studies

Website outages and upgrades

Human medicines European public assessment report (EPAR): Gilenya, fingolimod, Date of authorisation: 17/03/2011, Revision: 43, Status: Authorised

Human medicines European public assessment report (EPAR): Xbryk, denosumab, Date of authorisation: 12/02/2025, Revision: 3, Status: Authorised

List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment

Human medicines European public assessment report (EPAR): Pemetrexed Baxter, pemetrexed, Date of authorisation: 09/12/2022, Status: Withdrawn

Agenda of the PRAC meeting 28 September - 1 October 2026

Reform of the EU pharmaceutical legislation